Tirzepatide
A dual GIP/GLP-1 receptor agonist that activates both incretin receptors for superior weight loss. Regulates blood sugar, suppresses appetite, and increases feelings of fullness.
Key Benefits for Med Spas
Clinical Evidence
"Patients achieved 16.5% to 22.4% body weight reduction in a 72-week clinical trial."
Administration
Available Options
Wholesale pricing. Contact us for volume discounts and custom orders.
Quick Facts
Related Products
View allSemaglutide
A GLP-1 receptor agonist that mimics the naturally occurring GLP-1 hormone. Stimulates insulin secretion, suppresses appetite, and slows gastric emptying for powerful weight management.
Retatrutide
An investigational triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors. Regulates appetite, increases energy expenditure, and improves metabolic function for extreme weight loss.
AOD-9604
A modified fragment of human growth hormone that isolates fat-burning properties. Stimulates lipolysis and inhibits lipogenesis without affecting blood sugar or tissue growth.